Deutsche Bank AG Has $971,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Deutsche Bank AG lifted its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 53.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 74,023 shares of the company's stock after buying an additional 25,663 shares during the period. Deutsche Bank AG owned 0.09% of Pediatrix Medical Group worth $971,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of MD. Nomura Asset Management Co. Ltd. raised its stake in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the period. Parkside Financial Bank & Trust raised its stake in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the period. AlphaQuest LLC raised its stake in Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC raised its stake in Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after purchasing an additional 6,090 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Wall Street Analysts Forecast Growth

MD has been the subject of several recent research reports. Truist Financial dropped their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. UBS Group reduced their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 12th. Finally, Macquarie raised their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Stock Performance

NYSE:MD traded down $0.08 during trading hours on Friday, hitting $14.15. 968,608 shares of the company traded hands, compared to its average volume of 855,808. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The firm has a 50-day moving average of $13.72 and a 200 day moving average of $14.03. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business's quarterly revenue was down 7.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.20 EPS. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.